{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:17:47Z","timestamp":1784330267456,"version":"3.55.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cll.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T22:22:54Z","timestamp":1526422974000},"page":"367-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract"],"prefix":"10.1016","volume":"38","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Bluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarpreet","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cll.2018.03.003_bib2","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.14694\/EDBK_159117","article-title":"The past, present, and future of pancreatic cancer clinical trials","volume":"35","author":"Matrisian","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.cll.2018.03.003_bib3","series-title":"World Health Organization classification of tumours of the digestive system","first-page":"279","article-title":"Ductal adenocarcinoma of the pancreas","author":"Hruban","year":"2010"},{"key":"10.1016\/j.cll.2018.03.003_bib4","series-title":"Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract and pancreas","first-page":"1081","article-title":"Tumors of the pancreas","author":"Klimstra","year":"2014"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mc.20855","article-title":"Genetic susceptibility to pancreatic cancer","volume":"51","author":"Klein","year":"2012","journal-title":"Mol Carcinog"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/ijbs.15001","article-title":"Pancreatic cancer genetics","volume":"12","author":"Amundadottir","year":"2016","journal-title":"Int J Biol Sci"},{"issue":"5","key":"10.1016\/j.cll.2018.03.003_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.seminoncol.2016.09.002","article-title":"Familial pancreatic cancer","volume":"43","author":"Petersen","year":"2016","journal-title":"Semin Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.cll.2018.03.003_bib8","first-page":"S27","article-title":"WHO classification of digestive tumors: the fourth edition","volume":"31","author":"Flejou","year":"2011","journal-title":"Ann Pathol"},{"issue":"7424","key":"10.1016\/j.cll.2018.03.003_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"issue":"5897","key":"10.1016\/j.cll.2018.03.003_bib11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"issue":"7540","key":"10.1016\/j.cll.2018.03.003_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib14","first-page":"545","article-title":"K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization","volume":"143","author":"Hruban","year":"1993","journal-title":"Am J Pathol"},{"issue":"7592","key":"10.1016\/j.cll.2018.03.003_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cll.2018.03.003_bib16","first-page":"2140","article-title":"p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma","volume":"57","author":"Moskaluk","year":"1997","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000658-199910000-00006","article-title":"Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy","volume":"230","author":"Jimenez","year":"1999","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.cll.2018.03.003_bib18","first-page":"2002","article-title":"Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression","volume":"60","author":"Wilentz","year":"2000","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.50.6.861","article-title":"Aberrant p16(INK4A) and DPC4\/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma","volume":"50","author":"Biankin","year":"2002","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9440(10)64589-0","article-title":"Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas","volume":"157","author":"Lacobuzio-Donahue","year":"2000","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.cll.2018.03.003_bib21","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/00000478-200011000-00011","article-title":"Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression","volume":"24","author":"Lacobuzio-Donahue","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","article-title":"A\u00a0combination of molecular markers and clinical features improve the classification of pancreatic cysts","volume":"149","author":"Springer","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1186\/s40064-016-2847-4","article-title":"KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis","volume":"5","author":"Lee","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/modpathol.2014.98","article-title":"Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas","volume":"28","author":"Sakamoto","year":"2015","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.gastro.2015.05.021","article-title":"Adjunctive molecular analysis of pancreatic cyst fluid to determine malignant potential","volume":"149","author":"DiMaio","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4253\/wjge.v10.i1.1","article-title":"Confocal endomicroscopy and cyst fluid molecular analysis: comprehensive evaluation of pancreatic cysts","volume":"10","author":"Li","year":"2018","journal-title":"World J Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib27","first-page":"217","article-title":"Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis","volume":"117","author":"Shen","year":"2009","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.cll.2018.03.003_bib28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/2159-8290.CD-14-0617","article-title":"Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes","volume":"4","author":"Chmielecki","year":"2014","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cdp.2006.05.002","article-title":"Selected polymorphisms of DNA repair genes and risk of pancreatic cancer","volume":"30","author":"Jiao","year":"2006","journal-title":"Cancer Detect Prev"},{"issue":"9","key":"10.1016\/j.cll.2018.03.003_bib30","first-page":"11579","article-title":"Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"10.1016\/j.cll.2018.03.003_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamasurg.2017.2631","article-title":"Clinical and genetic implications of DNA mismatch repair deficiency in patients with pancreatic ductal adenocarcinoma","volume":"152","author":"Cloyd","year":"2017","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5858\/133.3.350","article-title":"Endocrine neoplasms of the pancreas: pathologic and genetic features","volume":"133","author":"Capelli","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.cll.2018.03.003_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1159\/000448699","article-title":"Efficacy and long-term safety of everolimus in pancreatic neuroendocrine tumor associated with multiple endocrine neoplasia type I: case report","volume":"39","author":"Maia","year":"2016","journal-title":"Oncol Res Treat"},{"issue":"6021","key":"10.1016\/j.cll.2018.03.003_bib34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)65289-3","article-title":"Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms","volume":"154","author":"Gortz","year":"1999","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<258::AID-GCC11>3.0.CO;2-2","article-title":"Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors","volume":"26","author":"Hessman","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00019606-199909000-00001","article-title":"Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN","volume":"8","author":"Komminoth","year":"1999","journal-title":"Diagn Mol Pathol"},{"issue":"2","key":"10.1016\/j.cll.2018.03.003_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.1180","article-title":"Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL","volume":"32","author":"Moore","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.cll.2018.03.003_bib42","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.22569","article-title":"Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"120","author":"Arnold","year":"2007","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2012.9","article-title":"Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy","volume":"9","author":"de Wilde","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cll.2018.03.003_bib44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1586\/17474124.2015.1092383","article-title":"Genetics of pancreatic neuroendocrine tumors: implications for the clinic","volume":"9","author":"Pea","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib45","first-page":"685","article-title":"Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation","volume":"143","author":"Hoorens","year":"1993","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","article-title":"Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.cll.2018.03.003_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00428-014-1562-1","article-title":"APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation","volume":"464","author":"Furlan","year":"2014","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00428-015-1882-9","article-title":"TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancer","volume":"468","author":"La Rosa","year":"2016","journal-title":"Virchows Arch"},{"issue":"23","key":"10.1016\/j.cll.2018.03.003_bib49","first-page":"8401","article-title":"Frequent beta-catenin mutation and cytoplasmic\/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm","volume":"61","author":"Tanaka","year":"2001","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib50","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)62563-1","article-title":"Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.2007.02949.x","article-title":"Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule","volume":"52","author":"Chetty","year":"2008","journal-title":"Histopathology"},{"issue":"52","key":"10.1016\/j.cll.2018.03.003_bib52","doi-asserted-by":"crossref","first-page":"21188","DOI":"10.1073\/pnas.1118046108","article-title":"Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways","volume":"108","author":"Wu","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"5","key":"10.1016\/j.cll.2018.03.003_bib53","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0002-9440(10)63008-8","article-title":"Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas","volume":"159","author":"Abraham","year":"2001","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)62580-1","article-title":"Beckwith-Wiedemann syndrome, pancreatoblastoma, and the Wnt signaling pathway","volume":"160","author":"Sullivan","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cll.2018.03.003_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.cll.2018.03.003_bib56","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/MPA.0b013e3182580fb4","article-title":"Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of pancreas: a meta-analysis","volume":"41","author":"Nissim","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.cll.2018.03.003_bib57","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MPA.0000000000000652","article-title":"Plectin as a biomarker of malignant progression in intraductal papillary mucinous neoplasms","volume":"45","author":"Moris","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.cll.2018.03.003_bib58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MPA.0000000000001002","article-title":"Effect of reprimo down-regulation on malignant transformation of intraductal papillary mucinous neoplasm","volume":"47","author":"Nakazato","year":"2018","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib59","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.cll.2018.03.003_bib60","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.3748\/wjg.v18.i35.4944","article-title":"Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?","volume":"18","author":"Sun","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.cll.2018.03.003_bib61","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.cll.2018.03.003_bib62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.cll.2018.03.003_bib63","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti\u2013PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cll.2018.03.003_bib64","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J\u00a0Immunother"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","article-title":"Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma","volume":"3","author":"Winograd","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1756283X16667909","article-title":"Immunotherapy in pancreatic cancer treatment: a new frontier","volume":"10","author":"Thind","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"10.1016\/j.cll.2018.03.003_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib68","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.29336","article-title":"Arginosuccinate synthetase 1\u00a0(ASS1): a marker of unclassified hepatocellular Adenoma and high bleeding risk","volume":"66","author":"Henriet","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cll.2018.03.003_bib69","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2017.07.009","article-title":"Molecular classification of hepatocellular adenoma in clinical practice","volume":"67","author":"Nault","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cll.2018.03.003_bib70","series-title":"Practical hepatic pathology: a diagnostic approach","first-page":"507","article-title":"Benign hepatocellular tumors","author":"Bioulac-Sage","year":"2018"},{"key":"10.1016\/j.cll.2018.03.003_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumor classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cll.2018.03.003_bib72","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.gtc.2017.01.009","article-title":"Morphologic subtypes of hepatocellular carcinoma","volume":"46","author":"Torbenson","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cll.2018.03.003_bib73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cll.2018.03.003_bib74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune specific class of Hepatocellular Carcinoma, Based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cll.2018.03.003_bib75","doi-asserted-by":"crossref","first-page":"24466","DOI":"10.1038\/srep24466","article-title":"Stratification of digestive cancers with different pathological features and survival outcomes by MicroRNA expression","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.cll.2018.03.003_bib76","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3748\/wjg.v20.i12.3112","article-title":"Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.003_bib77","series-title":"Practical hepatic pathology: a diagnostic approach","first-page":"555","article-title":"Liver tumors of childhood","author":"Zimmerman","year":"2018"},{"key":"10.1016\/j.cll.2018.03.003_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2016.08.013","article-title":"Molecular characteristics of biliary tract cancer","volume":"107","author":"Sohal","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"10.1016\/j.cll.2018.03.003_bib79","doi-asserted-by":"crossref","first-page":"14744","DOI":"10.18632\/oncotarget.4539","article-title":"Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies","volume":"6","author":"Brandi","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0034-1394144","article-title":"Cholangiocarcinoma: molecular pathways and therapeutic opportunities","volume":"34","author":"Rizvi","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cll.2018.03.003_bib81","series-title":"MacSween\u2019s pathology of the liver","first-page":"761","article-title":"Tumors and tumor like lesions of the liver","author":"Goodman","year":"2012"},{"issue":"10","key":"10.1016\/j.cll.2018.03.003_bib82","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jhbp.126","article-title":"Molecular mechanism of cholangiocarcinoma carcinogenesis","volume":"21","author":"Maemura","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"7","key":"10.1016\/j.cll.2018.03.003_bib83","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4251\/wjgo.v9.i7.268","article-title":"Emerging molecular targets and therapy for cholangiocarcinoma","volume":"9","author":"Kayhanian","year":"2017","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.cll.2018.03.003_bib84","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1309\/AJCP35FDCAVANWMM","article-title":"Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas","volume":"130","author":"Karamitopoulou","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.cll.2018.03.003_bib85","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880409","article-title":"Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma","volume":"14","author":"Sugimachi","year":"2001","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.cll.2018.03.003_bib86","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.510270412","article-title":"Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study","volume":"27","author":"Ashida","year":"1998","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cll.2018.03.003_bib87","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/jhep.2001.24028","article-title":"The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma","volume":"33","author":"Taguchi","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000012139","article-title":"Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes","volume":"59","author":"Ito","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.cll.2018.03.003_bib89","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cll.2018.03.003_bib90","doi-asserted-by":"crossref","first-page":"e0139305","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and\/or cholangiocarcinoma","volume":"10","author":"Voigtl\u00e4nder","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cll.2018.03.003_bib91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clinre.2016.10.007","article-title":"Identification of microRNAs as biomarkers for cholangiocarcinoma detection: a diagnostic meta-analysis","volume":"41","author":"Zhou","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"14","key":"10.1016\/j.cll.2018.03.003_bib92","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2217\/pgs-2017-0010","article-title":"miRNA profiling for diagnosis, prognosis, and stratification of cancer treatment in cholangiocarcinoma","volume":"18","author":"Puik","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cll.2018.03.003_bib93","series-title":"Surgical pathology of the GI tract, liver, biliary tract and pancreas","first-page":"1021","article-title":"Benign and malignant tumors of the gallbladder and extrahepatic biliary tract","author":"Volkan Adsay","year":"2009"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib94","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00000478-200206000-00009","article-title":"Mutation and altered expression of beta-catenin during gallbladder carcinogenesis","volume":"26","author":"Chang","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.cll.2018.03.003_bib95","first-page":"763","article-title":"Loss of heterozygosity in dysplasia and carcinoma of the gallbladder","volume":"12","author":"Chang","year":"1999","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.cll.2018.03.003_bib96","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0002-9440(10)61157-1","article-title":"Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma","volume":"160","author":"Wistuba","year":"2002","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.cll.2018.03.003_bib97","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.3880231","article-title":"Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis","volume":"13","author":"Batheja","year":"2000","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.cll.2018.03.003_bib98","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/1097-0142(20010401)91:7<1332::AID-CNCR1136>3.0.CO;2-4","article-title":"Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts","volume":"91","author":"Argani","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cll.2018.03.003_bib99","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3748\/wjg.14.70","article-title":"Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary","volume":"14","author":"Nagahashi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.003_bib100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cancergen.2017.08.006","article-title":"Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer","volume":"218-219","author":"Vietsch","year":"2017","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cll.2018.03.003_bib101","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.31024","article-title":"Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging","volume":"141","author":"Henriksen","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2018.03.003_bib102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13148-016-0286-2","article-title":"Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma","volume":"8","author":"Henriksen","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.cll.2018.03.003_bib103","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691681","article-title":"Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients","volume":"39","author":"Shi","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cll.2018.03.003_bib104","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MPA.0000000000000487","article-title":"DNA hypermethylation as a blood-based marker for pancreatic cancer: a literature review","volume":"44","author":"Henriksen","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.cll.2018.03.003_bib105","doi-asserted-by":"crossref","first-page":"e0182562","DOI":"10.1371\/journal.pone.0182562","article-title":"The prognostic value of KRAS mutation by cell-free DNA in cancer patients: a systematic review and meta-analysis","volume":"12","author":"Zhuang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cll.2018.03.003_bib106","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.3748\/wjg.v22.i25.5627","article-title":"Liquid biopsy in patients with pancreatic cancer: circulating tumor cells and cell-free nucleic acids","volume":"22","author":"Imamura","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.003_bib107","doi-asserted-by":"crossref","first-page":"43419","DOI":"10.18632\/oncotarget.9728","article-title":"Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121830012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121830012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T19:03:27Z","timestamp":1661281407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027227121830012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S027227121830012X"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2018.03.003","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}